U.S. Markets closed

Mirati: 3Q Earnings Snapshot

SAN DIEGO (AP) _ Mirati Therapeutics Inc. (MRTX) on Monday reported a loss of $54.3 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of $1.38.

The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.27 per share.

The biopharmaceutical company posted revenue of $988,000 in the period.

Mirati shares have more than doubled since the beginning of the year. In the final minutes of trading on Monday, shares hit $97.25, more than doubling in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRTX at https://www.zacks.com/ap/MRTX